吉尔伯特综合征

Watson KJ, Gollan JL. Gilbert's syndrome. Balliere's Clin Gastroenterol. 1989;3:337-355.

• 摘要

Bosma PJ, Chowdhury JR, Bakker C, et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med. 1995;333:1171-1175.

• 全文
• 摘要

1.  Watson KJ, Gollan JL. Gilbert's syndrome. Balliere's Clin Gastroenterol. 1989;3:337-355.

• 摘要

2.  Berg CL, Crawford JM, Gollan JL. Bilirubin metabolism and the pathophysiology of jaundice. In: Schiff ER, Sorrell MF, Maddrey WC, eds. Schiff's diseases of the liver. Philadelphia, PA: Lippincott-Raven; 1999:147-192.

3.  Saki F, Hemmati F, Haghighat M. Prevalence of Gilbert syndrome in parents of neonates with pathologic indirect hyperbilirubinemia. Ann Saudi Med. 2011;31:140-144.

• 全文
• 摘要

4.  Burchell B, Hume R. Molecular genetic basis of Gilbert's syndrome. J Gastroenterol Hepatol. 1999;14:960-966.

• 摘要

5.  Takeuchi K, Kobayashi Y, Tamaki S, et al. Genetic polymorphisms of bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese patients with Crigler-Najjar syndrome or Gilbert's syndrome as well as in healthy Japanese subjects. J Gastroenterol Hepatol. 2004;19:1023-1028.

• 摘要

6.  Bosma PJ, Chowdhury JR, Bakker C, et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med. 1995;333:1171-1175.

• 全文
• 摘要

7.  Chowdhury RJ, Chowdhury RN, Jansen P. Bilirubin metabolism and its disorders. In: Boyer TD, Wright TL, Manns MP, eds. Zakim and Boyer's hepatology. Philadelphia, PA: Saunders Elsevier; 2006:1449-1485.

8.  Monaghan G, Ryan M, Seddon R, et al. Genetic variation in bilirubin UDP-glucuronosyltransferase gene promoter and Gilbert's syndrome. Lancet. 1996;347:578-581.

• 摘要

9.  Strassburg CP. Gilbert-Meulengracht’s syndrome and pharmacogenetics: is jaundice just the tip of the iceberg? Drug Metab Rev. 2010;42:162-175.

• 摘要

10.  Minucci A, Concolino P, Giardina B, et al. Rapid UGT1A1 (TA)(n) genotyping by high resolution melting curve analysis for Gilbert’s syndrome diagnosis. Clin Chim Acta. 2010;411:246-249.

• 摘要

11.  Lee JS, Wang J, Martin M, et al. Genetic variation in UGT1A1 typical of Gilbert syndrome is associated with unconjugated hyperbilirubinemia in patients receiving tocilizumab. Pharmacogenet Genomics. 2011;21:365-374.

• 摘要

12.  Deterding K, Grüngreiff K, Lankisch TO, et al. Gilbert's syndrome and antiviral therapy of hepatitis C. Ann Hepatol. 2009;8:246-250.

• 摘要

13.  Gollan JL, Bateman C, Billing BH. Effect of dietary composition on the unconjugated hyperbilirubinemia of Gilbert's syndrome. Gut. 1976;17:335-340.

• 全文
• 摘要

14.  Black M, Sherlock S. Treatment of Gilbert's syndrome with phenobarbitone. Lancet. 1970;1:1359-1361.

• 摘要

15.  Ohkubo H, Okuda K, Iida S. Effects of corticosteroids on bilirubin metabolism in patients with Gilbert's syndrome. Hepatology. 1981;1:168-172.

• 摘要

16.  Ehmer U, Lankisch TO, Erichsen TJ, et al. Rapid allelic discrimination by TaqMan PCR for the detection of the Gilbert's syndrome marker UGT1A1*28. J Mol Diagn. 2008;10:549-552.

• 摘要

17.  Marques SC, Ikediobi ON. The clinical application of UGT1A1 pharmacogenetic testing: gene-environment interactions. Hum Genomics. 2010;4:238-249.

• 全文
• 摘要

18.  Hauser SC, Gollan J. Bilirubin metabolism and hyperbilirubinaemic disorders. In: Millward-Sadler GH, Wright R, Arthur MJ, eds. Wright's liver and biliary disease. London: W.B. Saunders; 1992:318-351.

19.  Očadlík I, Hlinštáková S, Oravec S. Relationship between unconjugated hyperbilirubinemia and lipoprotein spectrum. Neuro Endocrinol Lett. 2011;32:360-364.

• 摘要

20.  Tapan S, Karadurmus N, Dogru T, et al. Decreased small dense LDL levels in Gilbert's syndrome. Clin Biochem. 2011;44:300-303.

• 摘要

21.  Innocenti F, Iyer L, Ratain MJ. Pharmacogenetics. A tool for individualizing antineoplastic therapy. Clin Pharmacokinet. 2000;5:315-325.

• 摘要